38114-29-3

Basic information

• Product Name: erythro-methyl 2-amino-3-hydroxy-3-phenylpropanoate
• CAS NO: 38114-29-3
• Molecular Weight: 195.218
• Mol File: 38114-29-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: erythro-methyl 2-amino-3-hydroxy-3-phenylpropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: erythro-methyl 2-amino-3-hydroxy-3-phenylpropanoate(38114-29-3)
• EPA Substance Registry System: erythro-methyl 2-amino-3-hydroxy-3-phenylpropanoate(38114-29-3)

Safety Data

• Hazardous Substances Data: 38114-29-3(Hazardous Substances Data)

Upstream product

• 1807-69-8 2-diazo-3-oxo-3-phenyl-propionic acid methyl ester 
• 38061-23-3 α-Phenylacyl amino acid methyl ester hydrochloride 
• 147744-97-6 methyl 2-((tert-butoxycarbonyl)amino)-3-oxo-3-phenylpropanoate 
• 856908-46-8 phenylmethyl (Z)-4,5-dihydro-N-methoxy-4,4-dimethyl-2-oxazolecarboximidate 
• 856908-41-3 methyl (Z)-3-hydroxy-2-methoxyimino-3-phenylpropionate 
• 76717-86-7 2-amino-2-[2]furyl-1-phenyl-ethanol 
• 856908-45-7 phenylmethyl (Z)-N-methoxy-2-furancarboximidate 
• 17193-36-1 (2S*,3R*)-2-tert-butoxycarbonylamino-3-hydroxy-3-phenyl-propionic acid methyl ester 
• 186581-53-3 diazomethane 
• 69-96-5 dl-threo-phenylserine 
• 67-56-1 methanol 
• 100-52-7 benzaldehyde 
• 18020-59-2 methyl 3-hydroxy-2-methylidene-3-phenylpropionate 

Downstream Products

• 77809-03-1 (2RS,3RS)-3-acetoxy-2-acetylamino-3-phenyl-propionic acid methyl ester 
• 131975-60-5 (+/-)-2,5t-diphenyl-4,5-dihydro-oxazole-4r-carboxylic acid hydroxyamide 
• 17193-36-1 (2S*,3R*)-2-tert-butoxycarbonylamino-3-hydroxy-3-phenyl-propionic acid methyl ester 
• 129263-15-6 (+/-)-(4R,5R)-4-hydroxymethyl-5-phenyl-1,3-oxazolidin-2-one 
• 1104494-04-3 methyl (2R,3R)-2-(benzoylamino)-3-hydroxy-3-phenylpropanoate 
• 17193-36-1 (±)-(2R,3R)-2-tert-butoxycarbonylamino-3-hydroxy-3-phenylpropionic acid methyl ester 
• 1399362-68-5 C₄₃H₅₀N₈O₁₀S₂ 

Relevant articles and documents

GLP-1 RECEPTOR MODULATORS

Compounds are provided that modulate the glucagon-like peptide 1 (GLP-1) receptor, as well as methods of their synthesis, and methods of their therapeutic and/or prophylactic use. Such compounds can act as modulators or potentiators of GLP-1 receptor on their own, or with incretin peptides such as GLP-1(7-36) and GLP-1(9-36), or with peptide-based therapies, such as exenatide and liraglutide, and have the following general structure (where "^^^^" represents either or both the R and S form of the compound) (I) where A, B, C, Y1, Y2, Z, R1, R2, R3, R4, R5, W1, n, p and q are as defined herein.

Asymmetric synthesis of 2,4,5-trisubstituted Δ2- thiazolines

Δ2-Thiazolines are interesting heterocycles that display a wide variety of biological characteristics. They are also common in chiral ligands used for asymmetric syntheses and as synthetic intermediates. Herein, we present asymmetric routes to

Addition of azomethine ylides to aldehydes: Mechanistic dichotomy of differentially substituted α-imino esters

The formal 1,3-dipolar cycloaddition of azomethine ylides and aldehydes is explored, as hydrolysis of the resulting oxazolidine product gives facile access to valuable syn-β-arylβ-hydroxy-α-amino esters. The use of using benzaldehydederived imines as the ylide precursor results in 1,3-dipolar cycloaddition with high conversions but low diastereoselec-tivity. In contrast, the employment of benzophenone-derived imines as the ylide precursor results in an aldol reaction, which gives the intermediate oxazolidine in high diastereoselectivity and requires a weak acid catalyst to achieve higher conversions.